Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Overview of attention for article published in BMC Rheumatology, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 220)
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 20 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 409 followers.

Our new pharmacovigilance review on JAK Inhibitors in Psoriasis & P Arthritis, combines results from over 6700 patients, showing compelling improvement in standardized scores with reasonable safety. @sahilkoppikar @QueensuDOM @QueensUHealth @BU_BMC_Rhe

27 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.